Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice
by
Sansone M, Battaglia M, Vetulani J
Istituto di Psicobiologia e Psicofarmacologia,
CNR, Roma, Italy.
Pol J Pharmacol 1995 Jan-Feb; 47(1):69-73

ABSTRACT

The tricyclic antidepressant desipramine impaired shuttle-box avoidance acquisition in mice of the CD-1 strain. The nootropic drug oxiracetam was unable to prevent the desipramine-induced learning impairment, while a protective action was exerted by minaprine, a psychotropic agent regarded as an atypical antidepressant drug, possessing dopaminergic and related memory-enhancing properties. It seems likely that the dopaminergic action of minaprine played a determinant role in its avoidance improving effects in desipramine treated mice, because similar effects were produced by amphetamine. However, in contrast to amphetamine, minaprine did not enhance locomotor activity and did not show signs of general behavioral stimulation.

TCAs
Options
Minaprine
Dopamine
Oxiracetam
Dumb drugs
Smart drugs
Desipramine
Amphetamine
Minaprine: profile
Minaprine compared
Monkeys on minaprine
Minaprine v imipramine
Minaprine: mechanisms
Minaprine as an antidepressant
Minaprine, memory and dopamine
Minaprine, memory and acetylcholine
How effective are commonly prescribed antidepressants?

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family